Tirzepatide (Mounjaro for type 2 diabetes, Zepbound for weight management) is a dual GIP/GLP-1 receptor agonist that can lead to substantial weight loss
I hope to see some of you there
Heres the bottom line: Based on current research, semaglutide is safe for most people to use long-term, especially when monitored by a doctor
pharmacyregulation.org MHRA
The Controlled Substances Act schedules drugs based on abuse potential and accepted medical use
We used the following keywords: GLP-1, GLP-1 receptor agonist, exenatide, liraglutide, lixisenatide, semaglutide, albiglutide, dulaglutide, efpeglenatide, coronary artery disease, coronary atherosclerosis, endothelial dysfunction, inflammation, body weight, blood pressure, lipids, aggregation, coagulation, coronary vasospasm, coronary vasodilation, coronary microvascular, acute coronary syndrome, myocardial infarction, unstable angina, stable angina, chronic coronary syndrome, vasospastic angina, microvascular angina, coronary revascularization
